Ad
related to: latest news prostate cancer vaccines- Clinical Study Results
View Clinical Study Results
and Study Data Information.
- Clinical Glossary
Need Help Decoding Medical Words?
Our Clinical Glossary Can Help.
- Starting Treatment
Learn How to Find a Specialty
Pharmacy to Obtain Treatment.
- Real People, Real Stories
Visit Site to Watch Patient Videos
& Learn About Their Journey.
- Clinical Study Results
Search results
Results from the WOW.Com Content Network
PROSTVAC is being developed in partnership with the National Cancer Institute under a formal Cooperative Research and Development Agreement and has been the subject of multiple ongoing and completed clinical studies, including the global Phase 3 PROSPECT study underway in patients with asymptomatic or minimally symptomatic metastatic prostate cancer (mCRPC). [2]
A cancer vaccine, or oncovaccine, is a vaccine that either treats existing cancer or prevents development of cancer. [1] Vaccines that treat existing cancer are known as therapeutic cancer vaccines or tumor antigen vaccines. Some of the vaccines are "autologous", being prepared from samples taken from the patient, and are specific to that patient.
Vaccines targeting common gut bacteria E.coli could reduce rates of colon cancer in countries such as the UK, scientists have suggested. Professor Jukka Corander, senior author from the Wellcome ...
"For prostate cancer, I am a believer in the PSA (prostate-specific antigen) test, so am glad to see this statistic," one doctor told Fox News Digital. "PSA is a tool to guide you and not an ...
GVAX is a cancer vaccine composed of whole tumor cells genetically modified to secrete the immune stimulatory cytokine, granulocyte-macrophage colony-stimulating factor (GM-CSF), and then irradiated to prevent further cell division.
In the United States, 1 out of every 9 men will be diagnosed with prostate cancer in his lifetime. Scary news, but here’s something positive: The number of deaths due to the disease has plunged ...
A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer. [18] Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer [19]
The TALAPRO-2 results show how we continue innovating to improve survival for men with prostate cancer, which is the second most common cancer in men and the fifth most common cause of cancer ...
Ad
related to: latest news prostate cancer vaccines